Immunisation against Helicobacter felis infection protects against the development of gastric MALT Lymphoma

Vaccine. 2004 Jun 30;22(20):2541-6. doi: 10.1016/j.vaccine.2003.12.014.

Abstract

The formation of mucosa-associated lymphoid tissue (MALT) in response to Helicobacter pylori infection is closely associated with the development of primary gastric MALT lymphoma.

Aim: To examine whether immunisation against Helicobacter felis can protect against development of MALT lymphoma.

Results: The majority of control infected mice demonstrated MALT formation (13/15) and five developed lymphoma. Fifteen immunised mice were protected against bacterial challenge, of which only five had evidence of MALT formation and none developed lymphoma. Interestingly, of the four mice in which immunisation failed, all developed MALT and two of these had lymphoma.

Conclusion: Effective immunisation against Helicobacter infection can protect against gastric MALT lymphoma. To our knowledge this is the first demonstration of vaccination protecting against a bacteria-induced malignancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Vaccines / immunology
  • Bacterial Vaccines / therapeutic use*
  • Helicobacter Infections / epidemiology
  • Helicobacter Infections / prevention & control*
  • Helicobacter felis / immunology*
  • Immunization
  • Lymphoma, B-Cell, Marginal Zone / microbiology
  • Lymphoma, B-Cell, Marginal Zone / pathology
  • Lymphoma, B-Cell, Marginal Zone / prevention & control*
  • Mice
  • Stomach Neoplasms / microbiology
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / prevention & control*

Substances

  • Bacterial Vaccines